Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Industry Salary/Salary Support/Employee (full time or part time) - Boston Scientific Corporation</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Boehringer Ingelheim; JenaValve; Janssen Pharmaceuticals; Faraday</li></ul>